Status:
COMPLETED
Adipocytokines in Endometrial Cancer
Lead Sponsor:
University of Surrey
Collaborating Sponsors:
Royal Surrey County Hospital NHS Foundation Trust
GRACE Group
Conditions:
Endometrial Cancer
Obesity
Eligibility:
FEMALE
Brief Summary
The number of women diagnosed with uterine cancer continues to rise each year. Since the early 1990s, there has been almost 55% rise in the United Kingdom (UK). 34% of endometrial cancer can be attrib...
Detailed Description
1. BACKGROUND Endometrial cancer is the most common malignancy of the female genital tract. It is the fourth most common cancer in the UK with around 9,500 new cases in 2017, current lifetime risk...
Eligibility Criteria
Inclusion
- Women diagnosed with endometrial cancer
- Age 18 or above
- Of sound mind so they can give informed consent
- Historical tissue sample/ blocks from previous cases in the laboratory in the University of Surrey, also be used if appropriate consent is in place.
Exclusion
- Under 18yrs age
- Unable to give consent /denies consent
Key Trial Info
Start Date :
April 12 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04697264
Start Date
April 12 2021
End Date
October 31 2023
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Surrey NHS Foundation Trust
Guildford, Surrey, United Kingdom, GU2 7XX